Australia markets closed

Masimo Corporation (MASI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
140.07-2.21 (-1.55%)
At close: 04:00PM EDT
140.00 -0.07 (-0.05%)
After hours: 07:53PM EDT

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000
https://www.masimo.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees2,200

Key executives

NameTitlePayExercisedYear born
Mr. Joseph E. KianiFounder, CEO & Chairman4.22MN/A1965
Mr. Micah YoungExec. VP of Fin. & CFO773.81k317.33k1979
Mr. Bilal MuhsinChief Operating Officer986.31kN/A1981
Mr. Thomas Samuel McClenahanExec. VP, Gen. Counsel & Corp. Sec.774.53kN/A1973
Mr. Tao Leopold LevyExec. VP of Bus. Devel.631.6kN/A1974
Mr. Yongsam LeeExec. VP & Chief Information OfficerN/AN/A1965
Dr. Steven J. BarkerChairman of Scientific Advisory Board & Chief Science OfficerN/AN/A1945
Mr. Eli KammermanVP of Bus. Devel. & Investor RelationsN/AN/AN/A
Mr. Jon ColemanPres of Worldwide Sales, Professional Services & Medical AffairsN/AN/A1964
Mr. Anand SampathExec. VP of Operations & Clinical ResearchN/AN/A1966
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Corporate governance

Masimo Corporation’s ISS governance QualityScore as of 1 September 2022 is 6. The pillar scores are Audit: 2; Board: 9; Shareholder rights: 4; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.